Case Report: Developed Infraocular Squamous Cell Carcinoma and Nasal Basal Cell Carcinoma in Xeroderma Pigmentosum

Icha Aisyah, Afif Nurul Hidayati

Abstract views = 238 times | downloads = 265 times


Introduction: Xeroderma pigmentosum (XP) is a rare autosomal recessive disease caused by a gene defect in nucleotide excision pathway named nucleotide excision repair (NER),  characterized by photosensitivity of the skin. Case: A 5 year old girl, 15 kgs, came with  brown and black spots on the entire body since she was 7 month old. These complaints were accompanied with itchiness and burning sensation. Since two years ago, a small bump appeared on the nose and below the left eye, increasingly enlarged, also easily  bled. She complained red and watery eyes since two weeks ago. Patient often felt glare. Physical examination all over the body found obtained multiple hypopigmented and hyperpigmented macules unsharply marginated with varying  size from pinpoint to few cm and also dry skin. Right and left opthalmic region showed red, watery eye, and photophobia.  Nasal region showed nodules about 1 cm in size, accompanied by erosion and crusting. Histopathology examination result of left infraoculi  region was malignant squamous cell carcinoma and nasal region was malignant basal cell carcinoma. Patient were diagnosed with XP with infraocular squamous cell carcinoma and nasal basal cell carcinoma. Patient was treated with natrium fusidic 2% cream, sunscreen with sun protecting factor (SPF) 30, moisturizer, chlorpheniramine maleate, chemotherapy, and also educated to avoid sun exposure. Discussion: XP causes a variety of clinical manifestations, often with a skin malignancies. Skin biopsy is mandatory to establish the diagnosis


xeroderma pigmentosum; photosensitivity; skin malignancies;

Full Text:




Mallesh M, Purushothama RK. Xeroderma pigmentosum: a review. World J Pharm Sci 2015;4(2):1170-6.

Feller L, Wood NH, Motswaledi MH, Khammisa RA, Meyer M, Lemmer L. Xeroderma pigmentosum: a case report and review of the literature. J Prev Med Hyg 2010; 51: 87-91.

Nayak RR, Kamath GM, Kamath MM, Kamath AR, D'Souza S, Roopashree. Ocular surface squamous neoplasia in xeroderma pigmentosum. Online J Health Allied Scs 2013;12(3):15.

Chaudary M, Suhas N, Jajoo, Agarwal R. Xeroderma pigmentosum: a case report of two siblings. J Immunodefic Disor 2012;1:2.1-3.

Butt FM, Moshi JR, Owibingire S, Chindia ML.Xeroderma pigmentosum: a review and case series. J Craniomaxillofac Surg 2010;38: 534-537.

Sethi M, Lehmann AR, Fassihi H. Xeroderma pigmentosum: a multidisciplinary approach. EMJ Dermatol 2013;1:54-63.

Rao TN, Bhagyalaxmi A, Ahmed K, Mohana Rao TS, Venkatachalam K A case of melanoma in xeroderma pigmentosum. Indian J Pathol Microbiol 2009;52: 524-526.

Lehmann AR, McGibbon D, Stefanini M. Xeroderma pigmentosum. Orphanet J Rare Dis 2011;6:70.

Black JO. Xeroderma pigementosum. Head Neck Pathol 2016; 10(2):139-44.

Runger TM, digiovanna JJ, Kraemer KH. Hereditary disorders of genome instability and DNA repair. In: Goldsmith LA, Katz SI, Gilchrest BA, Leffel DJ, Wolff K, editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw-Hill; 2012.p1654-71.

James WD, Berger TG, Elston DM. Xeroderma pigmentosum. Andrews clinical dermatology 12thed.Philladelphia: Saunders Elsevier; 2015. p. 572-3

Fassihi H. Spotlight on xeroderma pigmentosum. Photochem Photobiol Sci 2013;12(1):78-84.

Karass M, Naguib MM, Elawabdeh N, Cundiff CA, Thomason J, Steelman CK, et al. Xeroderma pigmentosa: three new cases with an in depth review of the genetic and clinical characteristics of the disease. Fetal Pediatr Pathol 2015;34(2):120-7.

Rapin I, Lindenbaum Y, Dickson DW, Kraemer KH, Robbins JH. Cockayne syndrome and xeroderma pigmentosum. Neurology 2000;55(10):1442-9.

Karki S, Pandey G, Bhattarai N. Myrid of histopathological features of malignancy in xeroderma pigmentosum. Journal of Pathology of Nepal 2013; 3:472-5.

Mohanty P, Mohanty L, Devi BP. Multiple cutaneous malignancies in Xeroderma Pigmentosum. Indian J Dermatol Venereol Leprol 2001;67:96-7.

Bradford PT, Goldstein AM, Tamura D. Cancer and neurological degeneration in Xeroderma Pigmentosum: long term follow up characterizes the role of DNA repair. J Med Genet 2011;48:168-76.

Mareddy S, Reddy J, Babu S, Balan P.Xeroderma pigmentosum: man deprived of his right to light. Scientific World J 2013;1-8.

Kraemer KH, Digiovanna JJ. Forty years of research on xeroderma pigmentosum at the US national institutes of health. Photochem.Photobiol 2015;91: 452-9.

Tamura D1, DiGiovanna JJ, Khan SG, Kraemer KH. Living with xeroderma pigmentosum: comprehensive photoprotection for highly photosensitive patients. Photodermatol Photoimmunol Photomed. 2014;30(2):146-52.


  • There are currently no refbacks.

Copyright (c) 2018 Berkala Ilmu Kesehatan Kulit dan Kelamin



Lisensi Creative Commons
Creations are distributed below Lisensi Creative Commons Atribusi-NonKomersial 4.0 Internasional.

View My Stats